In addition, IRE1α-XBP1 signalling increased PD-L1 expression in TAMs and thus promoted melanoma growth [182], suggesting that targeting IRE1α-XBP1 signalling to TAMs combined with anti-PD-L1 therapy may be an effective strategy for the treatment of melanoma. This evidence concerns the gene CD274 and melanoma.